Phase I imaging study of the HER3 antibody RG7116 using 89Zr-RG7116-PET in patients with metastatic or locally advanced HER3-positive solid tumors.
Frederike Bensch
No relevant relationships to disclose
Laetitia E. Lamberts
No relevant relationships to disclose
Marjolijn N. Lub-de Hooge
No relevant relationships to disclose
Anton G.T. Terwisscha van Scheltinga
No relevant relationships to disclose
Johan R. de Jong
No relevant relationships to disclose
Jourik A. Gietema
Research Funding - AbbVie; Roche; Siemens
Carolien P. Schroder
No relevant relationships to disclose
Michiel M. Smeenk
No relevant relationships to disclose
Wolfgang Jacob
Employment or Leadership Position - Roche
Keelara Abiraj
Employment or Leadership Position - Roche
Michaela Wolf
Employment or Leadership Position - Roche
Stock Ownership - Roche
Celine Adessi
Employment or Leadership Position - Roche
Georgina Meneses-Lorente
Employment or Leadership Position - Roche
Stock Ownership - Roche
Magdalena Zajac
Employment or Leadership Position - Roche
Martin Weisser
Employment or Leadership Position - Roche
Stock Ownership - Roche
Adrienne H. Brouwers
No relevant relationships to disclose
Elisabeth De Vries
No relevant relationships to disclose